Global Atlanta recently sat down with Michel Abiteboul, the President of AFCROs on France. In the interview, he discussed the goals of how to bring and achieve high quality clinical trials in France. His interview is below:
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
April
(30)
- Inspirational Patient Perspective with NFL Legend ...
- Welcome to The Second and Final Day of the Conference
- Virtual Pharma: Addressing Challenges and Opportun...
- Understanding the Concepts of Disruptive Innovatio...
- Creating a Competitive Advantage through Sourcing
- Approaches to Address the Impact of Increasingly C...
- Clinical Trials: What Does Global Mean to You?
- MMAX: Development, Evolution, Growth and Maturatio...
- Leading Through Change: Innovation and the Future ...
- Wall Street’s 2009 Forecast and Analysis of Outsou...
- Live from the 18th Annual Partnerships with CROs
- Driving Global Growth: Strategic Considerations f...
- Governance and Supplier Relationship Management
- FierceBiotech is the Official Digital Media and Li...
- Speaker Profile: Peter B. Corr
- Speaker Profile: Harris Koffer, Pharm.D
- Speaker Profile: Christopher C. Gallen, MD, PhD
- Clinical trial begins for a malaria vaccine
- The Use of Bid Grids for Selecting a CRO as a Partner
- Partnerships with CROs April LinkedIn Update: Merg...
- Full Details are Required for Indian Clinical Trials
- Join us: Global Congress on Comparator Studies
- Partnerships with CROs & Other Outsourcing Provide...
- Patient recruitment costs continue to increase in ...
- Key Findings on CRO Industry
- France focuses on Clinical Trials
- CardioNet Expands into CRO Industry by Acquring Bi...
- The Political Economy of Pharmaceutical Clinical T...
- ICON teaming up with MedAvante
- New CenterWatch Report Examines Japan’s Surging Cl...
-
▼
April
(30)
No comments:
Post a Comment